5-bromo-4-chloroisatoic anhydride | 910123-20-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 5-bromo-4-chloroisatoic anhydride
• 英文别名: 5-Bromo-4-chloroisatoic anhydride；6-bromo-7-chloro-1H-3,1-benzoxazine-2,4-dione
• CAS: 910123-20-5
• 化学式: C₈H₃BrClNO₃
• 分子量: 276.474
• InChiKey: IEBYAAYLDQCODA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  14
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  5-bromo-4-chloroisatoic anhydride 在 potassium tert-butylate 、 sodium hydride 作用下， 以 乙醚 、 N,N-二甲基甲酰胺 为溶剂， 反应 9.25h， 生成 5-bromo-6-chloroindoxylic acid allyl ester
  参考文献：
  名称：

  吲哚乙酸酯作为吲哚氧基糖苷的方便中间体

  摘要：

  使用可扩展的路线以极好的收率获得了具有不同卤化物取代模式的吲哚酸甲酯和烯丙酯。这些关键中间体的相转移糖基化是用各种糖基卤化物进行的。随后温和的银介导的脱羧作用，然后是 Zemplen 脱乙酰作用，以良好的总产率得到吲哚酚苷。吲哚酚苷是酶筛选和酶活性监测的成熟和广泛使用的工具。过去，它们的合成一直很困难，因此这种新方法导致了各种有用的结构。

  DOI：

  10.1002/ejoc.201301198
• 作为产物：
  描述：

  N-(5-氯-2-甲基苯基)乙酰胺 在 吡啶 、 potassium permanganate 、 水 、 溴 、 magnesium sulfate 、 sodium hydroxide 作用下， 以 二氯甲烷 、 水 、 溶剂黄146 、 乙腈 为溶剂， 反应 18.0h， 生成 5-bromo-4-chloroisatoic anhydride
  参考文献：
  名称：

  吲哚乙酸酯作为吲哚氧基糖苷的方便中间体

  摘要：

  使用可扩展的路线以极好的收率获得了具有不同卤化物取代模式的吲哚酸甲酯和烯丙酯。这些关键中间体的相转移糖基化是用各种糖基卤化物进行的。随后温和的银介导的脱羧作用，然后是 Zemplen 脱乙酰作用，以良好的总产率得到吲哚酚苷。吲哚酚苷是酶筛选和酶活性监测的成熟和广泛使用的工具。过去，它们的合成一直很困难，因此这种新方法导致了各种有用的结构。

  DOI：

  10.1002/ejoc.201301198

文献信息

• Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors
  申请人：Mjalli M.M. Adnan

  公开号：US20060223849A1

  公开（公告）日：2006-10-05

  The present invention is directed to benzazole compounds that inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment or prevention of diseases in which BACE is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which BACE is involved.

  本发明涉及一种抑制β-淀粉样前体蛋白剪切酶（BACE）的苯并咪唑化合物，该化合物可用于治疗或预防BACE参与的疾病，如阿尔茨海默病。本发明还涉及包含这些化合物的药物组合物以及在预防或治疗BACE参与的这些疾病中使用这些化合物和组合物的用途。
• Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors
  申请人：Mjalli Adnan M.M.

  公开号：US20090326006A1

  公开（公告）日：2009-12-31

  The present invention is directed to benzazole compounds that inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment or prevention of diseases in which BACE is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which BACE is involved.

  本发明涉及抑制β位点淀粉样前体蛋白剪切酶（BACE）的苯并唑化合物，可用于治疗或预防BACE参与的疾病，如阿尔茨海默病。本发明还涉及包含这些化合物的药物组合物，以及在预防或治疗BACE参与的这些疾病中使用这些化合物和组合物的用途。
• Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors
  申请人：Mjalli Adnan M.M.

  公开号：US20110065713A1

  公开（公告）日：2011-03-17

  The present invention is directed to benzazole compounds that inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment or prevention of diseases in which BACE is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which BACE is involved.

  本发明涉及一种抑制 β-淀粉样前体蛋白裂解酶（BACE）的苯并咪唑化合物，该化合物可能在治疗或预防包括阿尔茨海默病在内的与BACE有关的疾病中有用。本发明还涉及包含这些化合物的药物组合物以及在预防或治疗BACE参与的这类疾病中使用这些化合物和组合物。
• Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors
  申请人：High Point Pharmaceuticals, LLC

  公开号：US07893267B2

  公开（公告）日：2011-02-22

  The present invention is directed to benzazole compounds that inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment or prevention of diseases in which BACE is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which BACE is involved.

  本发明涉及一种抑制β-淀粉样前体蛋白裂解酶（BACE）的苯并咪唑化合物，可用于治疗或预防BACE参与的疾病，如阿尔茨海默病。本发明还涉及包含这些化合物的制药组合物以及在预防或治疗BACE参与的这些疾病中使用这些化合物和组合物。
• Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
  申请人：High Point Pharmaceuticals, LLC

  公开号：EP2457901A1

  公开（公告）日：2012-05-30

  The present invention is directed to benzazole compounds that inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment or prevention of diseases in which BACE is involved, such as Alzheimer's disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which BACE is involved.

  本发明涉及抑制β位淀粉样前体蛋白切割酶（BACE）的苯甲唑化合物，这些化合物可用于治疗或预防BACE参与的疾病，如阿尔茨海默病。本发明还涉及包含这些化合物的药物组合物，以及这些化合物和组合物在预防或治疗涉及 BACE 的此类疾病中的用途。